Influence of nimodipine on neurological function ,serum levels of AQP4 and MIF in aged patients with hypertensive intracerebral hemorrhage
10.3969/j.issn.1008－0074.2019.05.21
- VernacularTitle:尼莫地平对老年高血压脑出血患者神经功能及血清 AQP4、MIF水平的影响
- Author:
Yun-Feng LI
1
;
Dan-Dan LU
;
Fang OUYANG
Author Information
1. 湖北省南漳县人民医院神经内科
- Keywords:
Hypertension;
Cerebral hemorrhage;
Nimodipine
- From:
Chinese Journal of cardiovascular Rehabilitation Medicine
2019;28(5):643-647
- CountryChina
- Language:Chinese
-
Abstract:
Objective :To study influence of nimodipine on neurological function and serum levels of aquaporin (AQP) 4 and macrophage migration‐inhibitory factor (MIF) in aged patients with hypertensive intracerebral hemorrhage (HICH).Methods :A total of 120 aged HICH patients treated in our hospital from Jan 2014 to Jan 2017 were ran‐domly and equally divided into routine treatment group (received puncture removal of hematoma + routine treat‐ment) and nimodipine group (received nimodipine based on routine treatment group ) ,both groups were treated for three weeks.United States National Institutes of Health Stroke Score (NIHSS) score ,brain edema volume ,serum levels of AQP4 ,MIF ,hsCRP and tumor necrosis factor (TNF)‐α ,therapeutic effect and incidence of adverse reac‐tion were measured and compared between two groups before and after treatment .Results :Total effective rate of nimodipine group was significantly higher than that of routine treatment group (88.33% vs .70.00%) , P＝0.013. Compared with routine treatment group after treatment ,there were significant reductions in NIHSS score [ (17.39 ± 3. 08) scores vs .(12. 26 ± 3.74) scores] ,brain edema volume [ (11. 84 ± 2.31) ml vs .(6.68 ± 1.93) ml] ,serum levels of AQP4 [ (2. 79 ± 0. 64) ng／ml vs .(1. 84 ± 0. 52) ng／ml] ,MIF [ (55.39 ± 7. 65) ng／L vs.(43.25 ± 5. 81) ng／L] ,hsCRP [ (18.83 ± 5. 17) mg／L vs.(12. 53 ± 3.87) mg／L] and TNF‐α [ (8. 42 ± 1.37) ng／L vs.(5. 78 ± 1.96) ng／L ] in nimodipine group , P＝0.001 all.There were no severe adverse reactions and no significant differ‐ence in incidence rate of adverse reactions between two groups , P＝0.436. Conclusion :Nimodipine can significantly improve therapeutic effect ,neurological function ,reduce serum AQP4 and MIF levels ,relieve brain edema and in‐flammation in aged HICH patients .
